Heart Failure Patient Conversion From LVAD To TAH Debated By Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA's Circulatory System Devices Panel has left the door open for cardiac surgeons to use SynCardia's CardioWest Total Artificial Heart (TAH) in transplant candidates who fail left ventricular assist device (LVAD) therapy